The Artificial Pancreas: A Race To The Finish
Executive Summary
The first fully functional artificial pancreas for patients with diabetes could be ready for regulatory submission in the next few years. Medtronic has achieved notable success in this area to date, but positive clinical studies have put J&J in a good position as well, and the medical community is watching closely as the major developments in this groundbreaking endeavor continue to move forward.
You may also be interested in...
FDA Approves Animas’ Vibe Linking Insulin Pump With DexCom CGM
The insulin pump is the first FDA-approved device featuring Dexcom’s G4 Platinum sensing technology; it allows patients to see glucose data and administer insulin directly from the pump.
Novo Nordisk Launches Cartridges For Roche Insulin Pumps
The companies say the new pre-filled insulin cartridges will make use of insulin pumps more convenient, which could be a boost for the insulin pump market.
Medtronic, Aetna Partner On Insulin Pump Cost-Savings Program
The device maker and insurance provider are collaborating to provide discounted Medtronic insulin pumps to Aetna members who have uncontrolled type 2 diabetes.